Filing Details
- Accession Number:
- 0001209191-14-043947
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-26 19:50:28
- Reporting Period:
- 2014-06-24
- Filing Date:
- 2014-06-26
- Accepted Time:
- 2014-06-26 19:50:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891288 | Questcor Pharmaceuticals Inc | QCOR | Pharmaceutical Preparations (2834) | 330476164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1378166 | David Young | 1300 North Kellogg Drive Suite D Anaheim CA 92807 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-24 | 6,000 | $4.54 | 117,741 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-24 | 6,000 | $91.96 | 117,741 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-06-24 | 6,000 | $0.00 | 6,000 | $4.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 71,000 | 2019-10-29 | No | 4 | M | Direct |
Footnotes
- Non-qualified stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on 10/30/2009.
- The option was granted on 10/30/2009 for the right to buy 350,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant with a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
- The prices reported in Column 4 are weighted average prices. These shares were sold in multiple transactions at prices ranging from $91.53 - $92.14. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form
Billionaire Hedge Funds
